Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study

Background. Paricalcitol and cinacalcet are common therapies for patients on haemodialysis with secondary hyperparathyroidism (SHPT). We conducted a multi-centre study in 12 countries to compare the safety and efficacy of paricalcitol and cinacalcet for the treatment of SHPT. Methods. Patients aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Ketteler, Markus, Martin, Kevin J., Cozzolino, Mario, Goldsmith, David, Sharma, Amit, Khan, Samina, Dumas, Emily, Amdahl, Michael, Marx, Steven, Audhya, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339443/
https://www.ncbi.nlm.nih.gov/pubmed/21931122
http://dx.doi.org/10.1093/ndt/gfr531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339443/
https://www.ncbi.nlm.nih.gov/pubmed/21931122
http://dx.doi.org/10.1093/ndt/gfr531

Ejemplares similares